J Knee Surg
DOI: 10.1055/a-2778-9046
Original Article

Do Medicare Advantage Patients Require More Follow-up to Complete Patient-Reported Outcome Measures After Total Knee Arthroplasty? An Analysis of 7,267 Medicare Patients

Authors

  • Benjamin E. Jevnikar

    1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
  • Khaled A. Elmenawi

    1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
  • Yuxuan Jin

    1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
  • Yuta Umeda

    1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
  • Ahmed K. Emara

    1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
  • Cleveland Clinic Adult Reconstruction Research (CCARR),
  • Nicolas S. Piuzzi

    1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States

Abstract

Patient-reported outcome measures (PROMs) are increasingly used to evaluate quality and guide reimbursement in total joint arthroplasty. While PROM collection is mandated for Traditional Medicare beneficiaries under value-based care models, little is known about how enrollment in Medicare Advantage (MA) affects PROM completion and follow-up burden in clinical practice. We analyzed a prospectively collected cohort of 7,267 Medicare patients who underwent primary total knee arthroplasty (TKA) between 2019 and 2023 at a large academic health system. Baseline and 1-year PROMs, including Knee Injury and Osteoarthritis Outcome Score for Joint Replacement, Physical Function Short Form (PS), Veterans RAND-12 Mental Component Score (MCS) were collected through a structured digital and manual follow-up protocol. Multivariable logistic regression assessed predictors of requiring active (manual) outreach for 1-year PROMs. PROM completion rates were significantly lower among MA patients at both baseline (74.2 vs. 80.3%, p < 0.001) and 1-year (53.5 vs. 61.9%, p < 0.001). However, MA enrollment was not independently associated with the need for active follow-up (odds ratio [OR] = 0.99, 95% confidence interval [CI] = 0.89–1.10; p = 0.79). Instead, increased follow-up burden was associated with older age (OR = 1.16 per interquartile range), non-White race (Black: OR = 1.89; Other: OR = 1.79), greater Area Deprivation Index (OR = 1.15), and poorer baseline physical/mental health (Pain − PS − MCS phenotype: OR = 1.40; all p < 0.01). While MA patients are less likely to complete PROMs after TKA, they do not place greater follow-up demands on clinical teams. Disparities in PROM capture appear to reflect underlying patient complexity rather than insurance design. As Centers for Medicare and Medicaid Services may expand PROM-based reimbursement models to include MA populations, equitable reporting will require targeted outreach and structural risk adjustment to avoid penalizing systems that serve more vulnerable groups.

Note

Members of CCARR: Robert M. Molloy, Trevor G. Murray, Viktor E. Krebs, Peter Surace, John P. McLaughlin, Michael R. Bloomfield, Alexander Roth, Nicholas Scarcella, Michael Erossy.




Publication History

Received: 13 November 2025

Accepted: 23 December 2025

Accepted Manuscript online:
29 December 2025

Article published online:
13 January 2026

© 2026. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Plate JF, Deen JT, Deans CF, Pour AE, Yates AJ, Sterling RS. Implementation of the new Medicare-mandated patient-reported outcomes after joint arthroplasty performance measure. J Arthroplasty 2024; 39 (05) 1136-1139
  • 2 Pasqualini I, Piuzzi NS. New CMS policy on the mandatory collection of patient-reported outcome measures for total hip and knee arthroplasty by 2027: what orthopaedic surgeons should know. J Bone Joint Surg Am 2024; 106 (13) 1233-1241
  • 3 Palmer R, Elmenawi KA, Lieberman JR, Heckmann ND, Hannon CP. Medicare reimbursement for primary and revision total hip and knee arthroplasty: an updated analysis from 2000 to 2024. J Arthroplasty 2025; 40 (9S1): S100-S104 , 104.e1
  • 4 Palmer RC, Elmenawi KA, Hannon CP, Lieberman JR, Heckmann ND. Medicare reimbursement for primary hip and knee arthroplasty is disproportionately decreasing relative to other high-volume inpatient procedures: leader of the pack. J Arthroplasty 2025; 40 (9S1): S105-S109
  • 5 Trish E, Valdez S, Ginsburg PB, Randall S, Lieberman SM. Substantial growth in Medicare Advantage and implications for reform. Health Aff (Millwood) 2023; 42 (02) 246-251
  • 6 Xu L, Welch WP, Sheingold S, De Lew N, Sommers BD. Medicare switching: patterns of enrollment growth in Medicare Advantage, 2006-22. Health Aff (Millwood) 2023; 42 (09) 1203-1211
  • 7 Elmenawi KA, Pasqualini I, Khan ST. et al; Cleveland Clinic Adult Reconstruction Research Group. Comparing Medicare and non-Medicare inpatient total knee arthroplasty: is the new Centers for Medicare and Medicaid Services patient-reported outcomes performance measure mandate applicable to all?. J Arthroplasty 2025; 40 (11) 2799-2804
  • 8 Wang JC, Piple AS, Chen XT. et al. The rise of Medicare Advantage: effects on total joint arthroplasty patient care and research. J Bone Joint Surg Am 2022; 104 (24) 2145-2152
  • 9 Shapiro LM, Bozic KJ, McClellan M, Spindler K. The new Centers for Medicare and Medicaid Services patient-reported outcome-based performance measure: what it means and how can I align. J Am Acad Orthop Surg 2025; 33 (10) e541-e550
  • 10 Landon BE, Zaslavsky AM, Anderson TS, Souza J, Curto V, Ayanian JZ. Differences in use of services and quality of care in Medicare Advantage and Traditional Medicare, 2010 and 2017. Health Aff (Millwood) 2023; 42 (04) 459-469
  • 11 Anderson KE, Wu RJ, Darden M, Jain A. Medicare Advantage is associated with lower utilization of total joint arthroplasty. J Bone Joint Surg Am 2024; 106 (03) 198-205
  • 12 Chen XT, Glasgow AE, Habermann EB. et al. The rise of Medicare Advantage is impacting the fidelity of Traditional Medicare claims data: implications for reporting of long-term total knee arthroplasty survivorship. J Bone Joint Surg Am 2025; 107 (12) 1371-1376
  • 13 Pasqualini I, Elmenawi KA, Khan ST, Klika AK, Zhang C, Piuzzi NS. Cleveland Clinic Adult Reconstruction Research Group. Inpatient Medicare total hip arthroplasties have distinct characteristics and are less likely to achieve substantial clinical benefit for hip disability and osteoarthritis outcome score for joint replacement: implications for Centers for Medicare and Medicaid Services patient-reported outcome measures policy. J Arthroplasty 2025; :S0883-5403(25)00908-8
  • 14 Jevnikar BE, Elmenawi KA, Jin Y, Khan ST, Piuzzi NS. Cleveland Clinic Adult Reconstruction Research (CCARR). Comparable PROM gains and satisfaction after TKA in Medicare Advantage vs. Traditional Medicare: a multivariable analysis of 6,010 patients. J Knee Surg 2025;
  • 15 Curtis GL, Tariq MB, Brigati DP, Faour M, Higuera CA. Cleveland Clinic Orthopaedic Arthroplasty Group. Validation of a novel surgical data capturing system following total hip arthroplasty. J Arthroplasty 2018; 33 (11) 3479-3483
  • 16 Cleveland OME. OME Cleveland Clinic Orthopaedics. Implementing a scientifically valid, cost-effective, and scalable data collection system at point of care: the Cleveland Clinic OME cohort. J Bone Joint Surg Am 2019; 101 (05) 458-464
  • 17 Cleveland OME. OME Cleveland Clinic Orthopaedics. Value in research: achieving validated outcome measurements while mitigating follow-up cost. J Bone Joint Surg Am 2020; 102 (05) 419-427
  • 18 Elmenawi KA, Pasqualini I, Khan ST. et al; Cleveland Clinic Adult Reconstruction Research (CCARR) Group. Expanding the scope of Centers for Medicare and Medicaid Services patient-reported outcome measures mandatory reporting: evaluating total hip arthroplasty outcomes beyond substantial clinical benefit for hip disability and osteoarthritis outcome score-joint replacement. J Arthroplasty 2025; 41: 329-334
  • 19 Gordon AM, Ng MK, Elali F, Piuzzi NS, Mont MA. A nationwide analysis of the impact of socioeconomic status on complications and health care utilizations after total knee arthroplasty using the area deprivation index: consideration of the disadvantaged patient. J Arthroplasty 2024; 39 (09) 2166-2172
  • 20 Khlopas A, Grits D, Sax OC. et al. Neighborhood socioeconomic disadvantages associated with prolonged lengths of stay, nonhome discharges, and 90-day readmissions after total knee arthroplasty. J Arthroplasty 2022; 37 (6S): S37-S43 , 43.e1
  • 21 Grits D, Emara AK, Klika AK, Murray TG, McLaughlin JP, Piuzzi NS. Neighborhood socioeconomic disadvantage associated with increased healthcare utilization after total hip arthroplasty. J Arthroplasty 2022; 37 (10) 1980-1986.e2
  • 22 Jevnikar BE, Huffman N, Pasqualini I. et al; CCARR Corporate Authorship. Neighborhood socioeconomic disadvantage is associated with increased health care utilization after septic and aseptic revision total hip arthroplasty. J Arthroplasty 2025; 40 (03) 550-558.e2
  • 23 Jevnikar BE, Huffman N, Roth A. et al; CCARR Corporate Authorship. Impacts of neighborhood deprivation on septic and aseptic revision total knee arthroplasty outcomes: a comprehensive analysis using the area deprivation index. Knee 2024; 51: 74-83
  • 24 Hadad MJ, Rullán-Oliver P, Grits D. et al. Racial disparities in outcomes after THA and TKA are substantially mediated by socioeconomic disadvantage both in Black and White patients. Clin Orthop Relat Res 2023; 481 (02) 254-264
  • 25 Emara AK, Sultan A, Grits D, Savage J, Piuzzi NS, Pelle DW. Opioid and sedative NarxCare Scores greater than 300 are associated with adverse outcomes after nonemergent spine surgery. Spine 2023; 48 (01) 29-38
  • 26 Khan ST, Pasqualini I, Rullán PJ, Tidd J, Piuzzi NS. Cleveland Clinic Arthroplasty Group. Predictive modeling of medical and orthopaedic-related 90-day-readmissions following primary total knee arthroplasty. J Arthroplasty 2025; 40 (02) 286-293.e2
  • 27 Orr MN, Klika AK, Gagnier JJ, Bhandari M, Piuzzi NS. A call for a standardized approach to reporting patient-reported outcome measures: clinical relevance ratio. J Bone Joint Surg Am 2021; 103 (22) e91
  • 28 Orr MN, Klika AK, Emara AK, Piuzzi NS. Cleveland Clinic Arthroplasty Group. Dissatisfaction after total hip arthroplasty associated with preoperative patient-reported outcome phenotypes. J Arthroplasty 2022; 37 (7S): S498-S509
  • 29 Rogers NB, Grits D, Emara AK. et al. Preoperative Veterans Rand-12 Mental Composite Score of < 40 leads to increased healthcare utilization and diminished improvement after primary knee arthroplasty. J Arthroplasty 2022; 37 (11) 2178-2185
  • 30 Grits D, Emara AK, Orr MN. et al. Preoperative Veteran RAND-12 Mental Composite Score of >60 associated with increased likelihood of patient satisfaction after total hip arthroplasty. J Arthroplasty 2023; 38 (7, Suppl 2): S258-S264
  • 31 Yayac MF, Harrer SL, Janiec DA, Courtney PM. Costs and outcomes of Medicare Advantage and Traditional Medicare beneficiaries after total hip and knee arthroplasty. J Am Acad Orthop Surg 2020; 28 (20) e910-e916
  • 32 DeClercq MG, Keeley JH, Runner RP. et al. Associated risk of Medicaid and Medicare payer status on outcomes following total joint arthroplasty: a 10-year report. J Arthroplasty 2025; 40 (09) 2275-2284.e1
  • 33 Elmenawi KA, Pasqualini I, Khan ST, Zhang C, Deren ME, Piuzzi NS. Lower 1-Year PROM completion rates and need for intensive follow-up in inpatient Medicare THA patients: implications for the CMS PROM policy. JBJS Open Access 2025; 10 (03) e25.00127
  • 34 Pasqualini I, Elmenawi KA, Khan ST, Gudapati LS, Piuzzi NS. Implementing the total hip and knee arthroplasty patient-reported outcome-based performance measure in outpatient and ambulatory surgical center settings: a practical review of new Centers for Medicare and Medicaid Services policies. J Arthroplasty 2025; :S0883-5403(25)01301-4
  • 35 Rullán PJ, Pasqualini I, Zhang C, Klika AK, Piuzzi NS. The Cleveland Clinic OME Arthroplasty Group. How to raise the bar in the capture of patient-reported outcome measures in total joint arthroplasty: results from active and passive follow-up measures. J Bone Joint Surg Am 2024; 106 (10) 879-890
  • 36 Schöner L, Kuklinski D, Wittich L. et al. Cost-effectiveness of a patient-reported outcome-based remote monitoring and alert intervention for early detection of critical recovery after joint replacement: a randomised controlled trial. PLoS Med 2024; 21 (10) e1004459
  • 37 Laverdiere J, Vaidya S, Panza G, Vye D, Bernstein J. Is it fair that patient-reported outcome measures completion is tied to reimbursement? patient demographics are associated with rates of PROM completion and potential health disparities. J Arthroplasty 2025; :S0883-5403(25)00831-9
  • 38 Konopka JA, Bloom DA, Lawrence KW, Oeding JF, Schwarzkopf R, Lajam CM. Non-English speakers and socioeconomic minorities are significantly less likely to complete patient-reported outcome measures for total hip and knee arthroplasty: analysis of 16,119 cases. J Arthroplasty 2023; 38 (7, Suppl 2): S69-S77
  • 39 Elmenawi KA, Emara AK, Khan ST. et al; Cleveland Clinic Adult Reconstruction Research Group. Greater resource utilization for patient-reported outcome measures collection in Medicare inpatient versus outpatient total knee arthroplasty: implications for the new Centers for Medicare and Medicaid Services PRO-PM policy. J Arthroplasty 2025; :S0883-5403(25)01306-3
  • 40 Sutton RM, Baker CM, D'Amore T, Courtney PM, Krueger CA, Austin MS. Poor patient compliance limits the attainability of patient-reported outcome measure completion thresholds for the comprehensive care for joint arthroplasty model. J Arthroplasty 2023; 38 (7, Suppl 2): S63-S68